Immatics (IMTX) Common Equity (2019 - 2026)
Immatics (IMTX) reported Common Equity of $464.51 million for Q2 2026, down 11.7% from $525.88 million a year earlier and down 13.0% from the prior quarter.
Powered by 
Analysis
Immatics (IMTX) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Immatics posted Common Equity of $546.94 million, down 12.1% from FY2024.
- Common Equity has a five-year compound annual growth rate of 40.5% (FY2020 to FY2025).
- By year, Common Equity came in at $622.17 million in FY2024 (+164.3%), $235.4 million in FY2023 (+9.8%), $214.33 million in FY2022 (+652.6%) and $28.48 million in FY2021 (-71.5%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q3 2024.
- Year over year, Common Equity has now declined in each of the last three quarters, with growth averaging 33.5% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q4 2022 (growth of 653.7%); the low point was Q4 2021 (a decline of 73.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $533.63 million (Q1 2026), $563.51 million (Q4 2025) and $487.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Immatics | 939.02 Mn | -1.09 Bn | - | 456.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 456.45 Mn |
| Mar 31, 2026 | 522.35 Mn |
| Dec 31, 2025 | 568.69 Mn |
| Sep 30, 2025 | 488.82 Mn |
| Jun 30, 2025 | 544.83 Mn |
| Mar 31, 2025 | 580.82 Mn |
| Dec 31, 2024 | 598.19 Mn |
| Sep 30, 2024 | 423.52 Mn |
| Jun 30, 2024 | 408.28 Mn |
| Mar 31, 2024 | 425.45 Mn |
| Dec 31, 2023 | 240.86 Mn |
| Sep 30, 2023 | 261.69 Mn |
| Jun 30, 2023 | 237.15 Mn |
| Mar 31, 2023 | 218.18 Mn |
| Dec 31, 2022 | 216.79 Mn |
| Sep 30, 2022 | 111.12 Mn |
| Jun 30, 2022 | 130.52 Mn |
| Mar 31, 2022 | 129.46 Mn |
| Dec 31, 2021 | 27.25 Mn |
| Sep 30, 2021 | 40.79 Mn |
API Access
Immatics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();